Lung fibroblasts from IPF patients and bleomycin-treated mice have demonstrated lower expression of PAI-1 in comparison to normal fibroblasts, with elevated levels of collagen type I and alpha-smooth muscle actin (α-SMA) in the IPF-derived fibroblasts [54]. The gene discussed is ACTA1; the disease is idiopathic pulmonary fibrosis.